載入...
ALK ligand ALKAL2 potentiates MYCN‐driven neuroblastoma in the absence of ALK mutation
High‐risk neuroblastoma (NB) is responsible for a disproportionate number of childhood deaths due to cancer. One indicator of high‐risk NB is amplification of the neural MYC (MYCN) oncogene, which is currently therapeutically intractable. Identification of anaplastic lymphoma kinase (ALK) as an NB o...
Na minha lista:
| 發表在: | EMBO J |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
John Wiley and Sons Inc.
2021
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7849294/ https://ncbi.nlm.nih.gov/pubmed/33411331 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15252/embj.2020105784 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|